Literature DB >> 21638091

Clinical scoring systems for stratifying risk after resection of hepatic colorectal metastases: still relevant?

William R Jarnagin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21638091     DOI： 10.1245/s10434-011-1821-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases.

Authors:  Junichi Shindoh; Evelyne M Loyer; Scott Kopetz; Piyaporn Boonsirikamchai; Dipen M Maru; Yun Shin Chun; Giuseppe Zimmitti; Steven A Curley; Chusilp Charnsangavej; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Clin Oncol       Date:  2012-11-13       Impact factor: 44.544

2.  RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.

Authors:  Giuseppe Zimmitti; Junichi Shindoh; Yoshihiro Mise; Scott Kopetz; Evelyne M Loyer; Andreas Andreou; Amanda B Cooper; Harmeet Kaur; Thomas A Aloia; Dipen M Maru; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2014-09-17       Impact factor: 5.344

3.  Hepatic Metastasis from Colorectal Cancer.

Authors:  Alan I Valderrama-Treviño; Baltazar Barrera-Mera; Jesús C Ceballos-Villalva; Eduardo E Montalvo-Javé
Journal:  Euroasian J Hepatogastroenterol       Date:  2017-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.